Balaxi Pharmaceuticals Market Cap

Balaxi Pharmaceuticals has a market cap or net worth of 2.70 billion as of May 8, 2025. Its market cap has decreased by -53.52% in one year.

Market Cap

2.70B

Enterprise Value

2.41B

Revenue

2.76B

Ranking

n/a

PE Ratio

10.56

Stock Price

52.16

Market Cap Chart

Since December 1, 2015, Balaxi Pharmaceuticals's market cap has increased from 41.50M to 2.70B, an increase of 6,398.23%. That is a compound annual growth rate of 55.64%.

Market Cap History

Date	Market Cap	% Change
May 6, 2025	2.69B	-26.97%
Dec 31, 2024	3.68B	-16.38%
Dec 29, 2023	4.40B	-27.68%
Dec 30, 2022	6.09B	18.63%
Dec 31, 2021	5.13B	-21.05%
Dec 31, 2020	6.50B	700.37%
Dec 31, 2019	Pro	Pro
Dec 19, 2017	Pro	Pro
Dec 8, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,406.62B
Divi's Laboratories	1,625.86B
Cipla	1,246.11B
Apollo Hospitals Enterprise	1,002.75B
Mankind Pharma	977.27B
Zydus Lifesciences	886.14B
Aurobindo Pharma	702.83B
Alkem Laboratories	608.05B

Market Cap Rankings